First, they slow down the rate at which food empties from the stomach, leading to increased feelings of fullness and satiety after meals
Clinicians are not immune to these societal trends and often lack sufficient knowledge about food, nutrition, and healthy food preparation
Precision is also paramount in terms of getting optimal treatment for people, and the appeal of different treatments might differ amongst people. GLP-1 Treatments Face Hurdles While GLP-1s offer promising benefits for some patients, significant barriers remain regarding supply, cost, and insurance coveragechallenges that Saunders describes as humongous limitations. Novo Nordisks Ozempic and Wegovy have been on the FDAs drug shortage list since 2022
10-13 In subsequent trials where higher doses of the GLP-1/GIP agonists were used in non-diabetic obese subjects, weight loss of 15% to 21% of body weight was seen
Accompanying this weight reduction, modest improvements in lipid parameters were observed
Another says Anthem denied everything